SCHEMBL6799229

SCHEMBL6799229

COCCOC(=O)C(CNC(=O)CC(C)CCC(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CHRM1 P11229 1/20 0.37
CTSB P07858 1/20 0.37
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP1A2 P05177 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
OPRM1 P35372 2/20 0.35
OPRK1 P41145 1/20 0.35
BCHE P06276 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8519689 1.00 HPGD (0.41) HPGDALDH1A1CHRM1CTSBCYP3A4
SCHEMBL6804827 0.80 HPGD (0.43) HPGDALDH1A1CHRM1KDM4ELMNA
SCHEMBL8386394 0.74 SMN1; SMN2 (0.41) HPGDALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL7649748 0.73 HPGD (0.44) HPGDALDH1A1CHRM1TSHRKDM4E
SCHEMBL17724576 0.73 CHRM1 (0.49) HPGDALDH1A1CHRM1CYP3A4CYP2D6
SCHEMBL9470496 0.72 ALDH1A1 (0.53) HPGDALDH1A1CTSBCYP3A4TSHR
SCHEMBL7299215 0.71 MMP2 (0.55) HPGDALDH1A1LMNA
SCHEMBL13445873 0.70 TDP1 (0.44) ALDH1A1CTSBCYP3A4TSHRMAPK1
SCHEMBL9222371 0.70 LTA4H (0.48) ALDH1A1CTSB
SCHEMBL8029749 0.70 CYP3A4 (0.37) ALDH1A1CTSBCYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6790834-B1 Cytostatic agents BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2004-09-14 US disclosed
US-6462023-B1 SUCH AS 2-HYDROXY-HYDROXYCARBAMOYL-METHYL)-4-METHYL-PENTANOYLAMINE)-2-PHENYL -ETHANOIC ACID CYCLOPENTYL ESTER; INHIBITING HYPERPROLIFERATIVE TUMOURGENIC CELLS SUCH AS MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2002-10-08 US disclosed
EP-0925278-B1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARM (GB) 2002-07-17 EP disclosed
US-6169075-B1 ANTITUMOR AGENT INHIBITING THE PROLIFERATION OF A RANGE OF RAPIDLY DIVIDING TUMOUR CELLS LIKE MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-01-02 US disclosed
EP-0925278-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-06-30 EP disclosed
WO-1998011063-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-03-19 WO disclosed